Zhu Shu, Professor and doctoral supervisor, Faculty of Life Science and Medicine, University of Science and Technology of China; Vice President, National Science Center of Hefei; Innovative Talent Program of the Organization Department of the CPC Central Committee (2017); Chief Scientist of Youth Project of Key R&D Program of Ministry of Science and Technology (2018), Youqing Foundation Committee (2018), National Jieqing (2023); Winner of MIT 35 Innovators under 35 China (2019), Qiushi Outstanding Young Scholars Award (2019), and Zhongyuan Union Innovation Breakthrough Award (2022).
His research focuses on immune recognition and immune regulation of intestinal microbes, as well as new microbial-related therapies. Published more than 60 articles, Corresponding author in Cell, Nature Biomedical Engineering, Nature Immunology, Cell Research, PNAS, Journals such as Nature Reviews Gastroenterology & Hepatology publish research and review papers. More than 7,000 citations, H index 35; As the first inventor, he has applied for 15 national invention patents and 3 PCT patents, of which 3 projects have been approved and entered the investigator-initiated clinical trial stage.
Recent work has shown how the innate immune system of the gut recognizes pathogenic microorganisms in the gut (Cell, 2021; Science Advance, 2022; Nature, 2017; Science, 2015), Symbiotic microorganisms (Nature Immunol, 2019) and food (Cell, 2023); Meanwhile, the mechanism of intestinal Dysbiosis was discovered (Cell Research, 2023; PNAS, 2020) and the development of Dysbiosis interventions for the treatment of infection and inflammation (Nature BME, 2022; Cell Reports, 2022).
